Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOCOX +/- Cetuximab in Metastatic Gastric/GEJ Cancer
NCT00517829Phase 2Completed
- Sponsor
- US Oncology Network
- Start
- Jul 2007
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by US Oncology Network. Started Jul 2007; status: completed.
02
Drugs
KL-140
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00517829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517829.